Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans

Advanced glycation end products (AGEs) are formed when glucose reacts nonenzymatically with proteins; these modifications are implicated in aging and pathogenesis of many age-related diseases including type II diabetes, atherosclerosis, and neurodegenerative disorders. Thus, pharmaceutical intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Golegaonkar, Sandeep, Tabrez, Syed S, Pandit, Awadhesh, Sethurathinam, Shalini, Jagadeeshaprasad, Mashanipalya G, Bansode, Sneha, Sampathkumar, Srinivasa-Gopalan, Kulkarni, Mahesh J, Mukhopadhyay, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406675/
https://www.ncbi.nlm.nih.gov/pubmed/25720500
http://dx.doi.org/10.1111/acel.12327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406675/
https://www.ncbi.nlm.nih.gov/pubmed/25720500
http://dx.doi.org/10.1111/acel.12327

Ejemplares similares